New research is challenging the long-held idea that depression is only a problem of mood or brain chemistry. Studies now show that in many people — especially those with atypical symptoms like overeating, oversleeping and strong mood swings — the immune system is overstimulated. This constant inflammation affects brain pathways and may help explain why many patients don’t respond well to standard antidepressants.
Scientists examining blood samples and lab-grown brain tissue found that immune cells in people with depression show genetic changes that make them more reactive and more inflammatory. At the same time, proteins involved in brain signaling were higher than normal, suggesting the brain is trying to adapt to stress signals coming from the immune system. These discoveries show that depression isn’t limited to the brain — it develops from a disrupted communication loop between the body and the nervous system.
The findings support a shift toward precision medicine in mental health. Instead of depending only on traditional antidepressants, future treatments may focus on inflammation, immune pathways and metabolic issues. By identifying measurable biological markers, this research could lead to earlier detection, more accurate diagnosis and more personalized therapies for people whose depression doesn’t improve with conventional care.
SOURCE: